Preparing for Gene Therapy Starts with Understanding Immunity – WFH
World Federation of Hemophilia – WFH shared a post on LinkedIn about a recent article by Hubert Darius J Daniel et al., published in Human Gene Therapy, adding:
“Preparing for gene therapy starts with understanding immunity.
This study examines baseline AAV antibody levels among people with and without hemophilia in India, informing screening approaches and access planning.”
Title: Total and Neutralizing Antibody Seroprevalence of Hepatotropic Adeno-Associated Virus Among Healthy and Hemophilia A or B Population from India
Authors: Hubert Darius J Daniel, Jaffar Farzana, Rajesh Kannangai, Sanjay Kumar, Kavitha M Lakshmi, Charnitkaur B Jashal, Hemant Dhamne, Varun Lahoti, Deepak Kanjwani, Aby Abraham, Kirsten Coleman, Arun Srivastava, Alok Srivastava, Asha Mary Abraham

More posts about World Federation of Hemophilia on Hemostasis Today.
-
Nov 17, 2026, 01:27X. Long Zheng: Optimizing Treatment in Immune TTP
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C